Union européenne - français - EMA (European Medicines Agency)

pfizer europe ma eeig  - axitinib - carcinome, cellule rénale - inhibiteurs de protéines kinases - inlyta is indicated for the treatment of adult patients with advanced renal cell carcinoma (rcc) after failure of prior treatment with sunitinib or a cytokine.

Canada - français - Health Canada

pfizer canada ulc - mitoxantrone (chlorhydrate de mitoxantrone) - solution - 2mg - mitoxantrone (chlorhydrate de mitoxantrone) 2mg - antineoplastic agents

Canada - français - Health Canada

sandoz canada incorporated - ciprofloxacine - solution - 10mg - ciprofloxacine 10mg - quinolones

Canada - français - Health Canada

apotex inc - gemcitabine (chlorhydrate de gemcitabine) - solution - 38mg - gemcitabine (chlorhydrate de gemcitabine) 38mg - antineoplastic agents

Canada - français - Health Canada

pfizer canada ulc - ciprofloxacine - solution - 2mg - ciprofloxacine 2mg - quinolones

Canada - français - Health Canada

baxter corporation - ciprofloxacine - solution - 2mg - ciprofloxacine 2mg - quinolones

Canada - français - Health Canada

fresenius kabi canada ltd - ciprofloxacine (lactate de ciprofloxacine) - solution - 10mg - ciprofloxacine (lactate de ciprofloxacine) 10mg - quinolones

Canada - français - Health Canada

fresenius kabi canada ltd - ciprofloxacine - solution - 2mg - ciprofloxacine 2mg - quinolones

Canada - français - Health Canada

telip, llc, a subsidiary of teligent, inc. - gemcitabine (chlorhydrate de gemcitabine) - poudre pour solution - 200mg - gemcitabine (chlorhydrate de gemcitabine) 200mg - antineoplastic agents

Canada - français - Health Canada

telip, llc, a subsidiary of teligent, inc. - gemcitabine (chlorhydrate de gemcitabine) - poudre pour solution - 1g - gemcitabine (chlorhydrate de gemcitabine) 1g - antineoplastic agents